Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Improved system for helper-dependent adenoviral vector production.

Donna Palmer1, Philip Ng

  • 1Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.

Molecular Therapy : the Journal of the American Society of Gene Therapy
|November 6, 2003
PubMed
Summary

Researchers developed a new system to overcome challenges in producing helper-dependent adenoviral vectors (HDAds) for gene therapy. This improved method enhances large-scale production and significantly reduces helper virus contamination, paving the way for clinical applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>In vivo</i> HSC gene therapy enables sustained eCD4-Ig expression for SIV prevention.

Molecular therapy. Advances·2026
Same author

Cytosine base editing of LPA in transgenic mice averts large deletions.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

Normal urinary oxalate excretion in 4-hydroxy-2-oxo-glutarate aldolase 1 (HOGA1) deficient mice with AGT expression in peroxisomes and not in mitochondria.

Biochimica et biophysica acta. Molecular basis of disease·2025
Same author

N-terminal eGFP-tagging of rabbit apolipoprotein A-I decreases expression and impairs cholesterol-efflux activity.

Biochimica et biophysica acta. Molecular and cell biology of lipids·2023
Same author

Mitochondrial dysfunction reactivates α-fetoprotein expression that drives copper-dependent immunosuppression in mitochondrial disease models.

The Journal of clinical investigation·2022
Same author

Binding of adenovirus species C hexon to prothrombin and the influence of hexon on vector properties in vitro and in vivo.

PLoS pathogens·2022

Area of Science:

  • Gene Therapy
  • Adenoviral Vector Technology
  • Molecular Biology

Background:

  • Helper-dependent adenoviral vectors (HDAds) offer significant potential for gene therapy due to their large cloning capacity and sustained transgene expression.
  • Current production methods, primarily the Cre/loxP system, face limitations in scalability and helper virus (HV) contamination.
  • These limitations impede the advancement of HDAd technology for therapeutic applications.

Purpose of the Study:

  • To develop an improved system for producing helper-dependent adenoviral vectors (HDAds).
  • To address the challenges of large-scale vector production and helper virus contamination.
  • To enhance the efficiency and purity of HDAd vectors for gene therapy.

Main Methods:

  • Development of an improved producer cell line and protocols.

Related Experiment Videos

  • Utilized a modified system to overcome limitations of the Cre/loxP method.
  • Evaluated vector yield, purity, and helper virus contamination levels.

    • Main Results:

    • Achieved production of >1 x 10(13) viral particles (vp) from 3 liters of cells within 2 weeks.
    • Demonstrated specific yields exceeding 10,000 vp/cell.
    • Reduced helper virus contamination to 0.4-0.1% without density-based purification and 0.02-0.01% with CsCl purification.

    Conclusions:

    • The new system significantly improves upon existing methods for HDAd production in terms of simplicity, speed, yield, and purity.
    • This advancement facilitates the assessment of HDAd gene therapy potential in large animal models and clinical settings.
    • The improved HDAd production system is crucial for the future development of gene therapy applications.